It appears that the Texas Rangers have made a significant addition to their pitching staff by signing right-hander Tyler Mahle to a two-year, $22 million deal. Mahle, 29, expressed excitement about joining the Rangers, citing the team’s commitment to winning and their efforts to build a competitive roster.
Tyler Mahle underwent Tommy John surgery in May, which means he won’t be available to pitch until midseason at the earliest. Despite the delayed start, the Rangers see Mahle as a valuable asset to their pitching rotation for both the 2024 and 2025 seasons. Before his injury, Mahle had a promising stint with the Cincinnati Reds, establishing himself as a reliable starter with a 3.72 ERA across 43 games (42 starts) in 2020-2021.
The Rangers’ general manager, Chris Young, expressed confidence in Mahle’s recovery and sees him as a mid-rotation starter with upside potential. Mahle, along with Jacob deGrom and Max Scherzer, is one of three starting pitchers set to return from injury for the Rangers in the second half of the 2024 season.
Mahle, known for his ability to locate his fastball, expressed that his success hinges on the command of his fastball, complemented by a splitter and slider. He is currently in a throwing program, approximately five weeks into his recovery post-surgery.
Mahle had multiple two-year offers on the table but chose the Rangers. He highlighted the team’s early interest in him, with the Rangers being the first to reach out after the World Series, demonstrating their eagerness to win and their commitment to building a competitive team.
Despite Mahle’s injury history, the Rangers seem optimistic about his future contributions to the team and view him as a key part of their pitching rotation moving forward.
OFFICIAL: We've signed RHP Tyler Mahle to a two-year contract. pic.twitter.com/ZNQVGRVKts
— Texas Rangers (@Rangers) December 14, 2023
Leave a Reply